Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check13 days agoChange DetectedThe webpage has updated its date references, removing older dates from May 2025 and adding new dates in June 2025. This indicates a shift in the timeline or schedule presented on the page.SummaryDifference0.3%
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check35 days agoChange DetectedThe page has been updated to reflect the latest version as v2.16.2, replacing the previous version v2.16.1. The estimated last update posted has been removed.SummaryDifference0.1%
- Check42 days agoChange DetectedThe page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check49 days agoChange DetectedThe web page has been updated to version 2.16.0, indicating a new revision. The previous version, 2.15.2, has been removed.SummaryDifference0.1%
Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.